/Artemisia
What in the world is going on in Africa?
APRIL 22, 2020:
The people of Madagascar are clearly doing something that is working.
And so are the people in Senegal, Burkina Faso, Liberia, and Tanzania.
On April 20, 2020, Madagascar's President Andry Rajoelina announced on a television broadcast that his country had found "preventive and curative" for COVID-19. Rajoelina publicly sipped from a bottle of Covid-Organics and ordered a nation-wide distribution to families.
Covid-Organics is an artemisia-based drink that was developed and produced in Madagascar by the Malagasy Institute of Applied Research. Madagascar was the first country to decide to integrate Artemisia into COVID-19 treatment
Artemisia is a plant that is cultivated and exported on the Big Island of Madagascar to help in the fight against malaria. “All trials and tests have been conducted and its effectiveness in reducing the elimination of symptoms has been proven for the treatment of patients with COVID-19 in Madagascar,” the president said.
A wide range of criticism followed the launch of Covid-Organics from within and outside Africa and the World Health Organization (WHO) issued a warning against using Covid-Organics.
A number of African and Caribbean countries have taken delivery of Covid-Organics to combat COVID-19.
Tanzania
Guinea Bissau
Nigeria
Democratic Republic of the Congo
Republic of Congo
Equatorial Guinea
Ghana
Liberia
Senegal
Republic of Chad
Comoros
Niger
Haiti
In vitro efficacy of Artemisinin-based treatments against SARS-CoV-2
https://www.biorxiv.org/content/10.1101/2020.10.05.326637v
African countries such as Madagascar, Senegal, Burkina Faso, Liberia, and Tanzania are showing death per million rates caused by COVID-19 lower than the rest of the countries in the world. This has been called the “African Miracle”.
If other countries were to do what these countries are doing in Africa, would the COVID-19 pandemic be reduced?
The information below is an excerpt from a recent article by Dr. José Luis Abreu, Ph.D.
Artemisia annua
Humanity is living an ongoing dramatic story where its survival is at risk. Can we have the luxury of turning our backs to a healing plant that already has shown excellent medicinal properties for thousands of years?
D’Alessandro et al (2020) have reported that in recent decades, drugs used to treat malaria infection have been shown to be beneficial for many other diseases, including viral infections. In particular, they have received special attention due to the lack of effective antiviral drugs against new emerging viruses (i.e., HIV, dengue virus, chikungunya virus, ebola virus, etc.) or against classic infections due to drugresistant viral strains (i.e., human cytomegalovirus).
They reviewed the in vitro/in vivo and clinical studies conducted to evaluate the antiviral activities of four classes of antimalarial drugs: Artemisinin derivatives, aryl-aminoalcohols, aminoquinolines, and antimicrobial drugs. Antimalarial drugs are usually divided based on the chemical structure or the source of the drugs. Most of them derive from traditional medicine and plants. They present different modes and various mechanisms of action, which are often still not elucidated, against malaria parasites.
Furthermore, due to the complexity of these molecules, additional side activities have been reported. For these reasons, antimalarial drugs have been studied, proposed, and sometimes used for the treatment of other pathologies, such as cancer, autoimmune diseases, and nonmalaria infectious diseases.
Moreover, the geographical overlaps between malaria and viral-related diseases have led to the consideration of possible use of antimalarial drugs as new antiviral drugs. Finally, the lack of new effective antiviral drugs and vaccines against many viral infections has strengthened interest in the potential antiviral activity of antimalarial drugs (D’Alessandro et al 2020).
In their study, D’Alessandro et al (2020) presented the use and the efficacy against human viruses of the principal antimalarial drugs, divided into four main groups: Artemisinin derivatives, arylaminoalcohols, aminoquinolines, and antimicrobial drugs.
Based on a detailed documentary research D’Alessandro et al (2020) concluded that the use of antimalarial drugs might be useful, especially in cases of antiviral resistance and in light of the emergence of many viruses against which effective drugs are not available.
Are African Countries showing the path to the solution of the COVID-19 problem?
Are there occurring unnecessary deaths in the world?
Humanity is living an ongoing dramatic story where its survival is at risk. Can we have the luxury of turning our backs to a healing plant that already has shown excellent medicinal properties for thousands of years?
D’Alessandro et al (2020) have reported that in recent decades, drugs used to treat malaria infection have been shown to be beneficial for many other diseases, including viral infections. In particular, they have received special attention due to the lack of effective antiviral drugs against new emerging viruses (i.e., HIV, dengue virus, chikungunya virus, ebola virus, etc.) or against classic infections due to drugresistant viral strains (i.e., human cytomegalovirus).
They reviewed the in vitro/in vivo and clinical studies conducted to evaluate the antiviral activities of four classes of antimalarial drugs: Artemisinin derivatives, aryl-aminoalcohols, aminoquinolines, and antimicrobial drugs. Antimalarial drugs are usually divided based on the chemical structure or the source of the drugs. Most of them derive from traditional medicine and plants. They present different modes and various mechanisms of action, which are often still not elucidated, against malaria parasites.
Furthermore, due to the complexity of these molecules, additional side activities have been reported. For these reasons, antimalarial drugs have been studied, proposed, and sometimes used for the treatment of other pathologies, such as cancer, autoimmune diseases, and nonmalaria infectious diseases.
Moreover, the geographical overlaps between malaria and viral-related diseases have led to the consideration of possible use of antimalarial drugs as new antiviral drugs. Finally, the lack of new effective antiviral drugs and vaccines against many viral infections has strengthened interest in the potential antiviral activity of antimalarial drugs (D’Alessandro et al 2020).
In their study, D’Alessandro et al (2020) presented the use and the efficacy against human viruses of the principal antimalarial drugs, divided into four main groups: Artemisinin derivatives, arylaminoalcohols, aminoquinolines, and antimicrobial drugs.
Based on a detailed documentary research D’Alessandro et al (2020) concluded that the use of antimalarial drugs might be useful, especially in cases of antiviral resistance and in light of the emergence of many viruses against which effective drugs are not available.
Are African Countries showing the path to the solution of the COVID-19 problem?
Are there occurring unnecessary deaths in the world?
Read Dr. Abreu's book:
CLICK ABOVE FOR DETAILS
